Validation of a UV-spectrophotometric analytical method for the determination of usnic acid in liposomes;Validação de método analítico espectrofotométrico UV para determinação de ácido úsnico em lipossomas

Revista Brasileira de Ciencias Farmaceuticas/Brazilian Journal of Pharmaceutical Sciences

Volumn 44, Issue 4, 2008, Pages 621-628

  De Siqueira Moura, Marigilson Pontes ^a   Lira, Mariane Cajubá Britto ^a   Santos Magalhães, Nereide Stela ^a  

^a FEDERAL UNIVERSITY OF PERNAMBUCO   (Brazil)

Author keywords

Liposomes; Quantitative analysis method's validation; Ultraviolet spectrophotometry; Usnic acid determination

Indexed keywords

DRUG CARRIER; LIPOSOME; USNIC ACID;

ACCURACY; ANALYTIC METHOD; ARTICLE; DRUG ACTIVITY; DRUG DETERMINATION; DRUG DOSAGE FORM; DRUG FORMULATION; QUANTITATIVE ANALYSIS; ULTRAVIOLET SPECTROPHOTOMETRY; VALIDATION STUDY;

EID: 59649095507     PISSN: 15169332     EISSN: None     Source Type: Journal    
DOI: 10.1590/S1516-93322008000400008     Document Type: Article

References (22)

1. CLOTHIER, Jr., J. G.; CARLSON, J. R.; COLWELL, D. J. Antiperspirant and deodorant compositions containing a low molecular weight polyethylene gellant. US Patente No. 6.375.938, Abril, 2002.
2. COCCHIETTO, M.; SKERT, N.; NIMIS, P.L.; SAVA, G. A review on usnic acid, an interesting natural compound. Naturwissenschaften, Berlin, v.89, n.4, p.137-146, 2002.
3. ELLIOTT, D. L.; COLWELL, D. J.; SANE, J. N.; VU, T.M.; GALANTE, C. L. Multi-portion antiperspirant composition. U.S. Patente No. 6.936.242, Agosto, 2005.
4. FERRARI, G.; GHIONE, M.; GHIRARDI, P. Composition containing usnic acid or its derivatives for the therapeutical control of dental caries, particularly for the treatment of the cariogenic dental plaque. Patente No. ZA8704549, Março, 1988.
5. GHIONE, M.; PARRELLO, D.; GRASSO, L. Usnic acid revisited, its activity on oral flora. Chemioterapia: Int. J. Medit. Soc. Chemother., Florence, v.7, n.5 p.302-305, 1988.
6. GRASSO, L.; GHIRARDI, P.E.; GHIONE, M. Usnic acid, a selective antimicrobial agent against Streptococcus mutans: a pilot clinical study. Cur. Ther. Res., Amsterdam, v.45, n.6, p.1067-1070, 1989.
7. GROSZ, R.; MOLONEY, M. J.; KLEINRATH, R.; SOLAN, J. L.; VAN DER LEE, H.; GALANTE, C.L. Methods of manufacturing personal care products. US Patente, No. 6.838.032, Janeiro, 2005.
8. MERCK INDEX. Encyclopedia of chemical, drugs and biologicals. 12 ed. New Jersey: Merck, 1995. p.9806.
9. ICH Q2(R1). Validation of Analytical Procedures: Text and Methodology. Disponível em: 〈http://www.ich.org/LOB/media/MEDIA417.pdf〉. Acesso em: 20 mar. 2007.
10. INGÓLFSDÓTTIR, K.; CHUNG, G.A.C.; SKÚLASON, V.; GISSURARSON, S.R.; VILHELMSDÓTTIR, M. Antimycobacterial activity of lichen metabolites in vitro. Eur. J. Pharm. Sci., Amsterdam, v.6, n.2, p.141-144, 1998.
11. JI, X.; KHAN, I.A. Quantitative determination of usnic acid in usnea lichen and its products by reversed-phase liquid chromatography with photodiode array detector. J. AOAC Int., Gaithersburg, v.88, n.5, p.1265-1268, 2005.
12. LASIC, D.D. Liposomes: From physics to application. Amsterdam: Elsevier, 1993. p.3-7.
13. LAUTERWEIN, M.; OETHINGER, M.; BELSNER, K.; PETERS, T.; MARRE, R. In vitro activities of the lichen secondary metabolites vulpinic acid, (+)-usnic acid, and (-)-usnic acid against aerobic and anaerobic microorganisms. Antimicrob. Agents Chemother., Bethesda, v.39, n.11, p.2541-2543, 1995.
14. LODETTI, G.; GOGOLA, P.; BERTASI, B.; D'AMBROSCA, F.; PONCHIO, G.; FISCHBACH, M.; LOSIO, M.N. Valutazione in vitro della citotossità indotta da prodotti per l'igiene orale contenenti acido usnico, agente antimicrobiano naturale estratto dai licheni. G. Ital. Microbiol. Med., Milano, v.4, n. , p.67-72, 2000.
15. NEFF, G. W.; REDDY, K. R.; DURAZO, F. A.; MEYER, D.; MARRERO, R; KAPLOWITZ, N. Severe hepatotoxicity associated with the use of weight loss diet supplements containing ma huang or usnic acid. Letters to the Editor/ J. Hepatol., v.41, p.1061-1067, 2004.
16. PÉREZ-LOZANO, P.; GARCÍA-MONTOYA, E.; ORRIOLS, A.; MIÑARRO, M.; TICÓ, J.R.; SUÑÉ-NEGRE, J.M. Development and validation of a new HPLC analytical method for the determination of alprazolam in tablets. J. Pharm. Biomed. Anal., Amsterdam, v.34, n.5, p.979-987, 2004.
17. RIBEIRO-COSTA, R.M.; ALVES, A.J.; SANTOS, N.P.; NASCIMENTO, S.C.; GONÇALVES, E.C.P.; SILVA, N.H.; HONDA, N.K.; SANTOS-MAGALHÃES, N.S. In vitro and in vivo properties of usnic acid encapsulated into PLGA-microspheres. J. Microencapsul., London, v.21, n.4, p.371-384, 2004.
18. SANTOS, N.P.; NASCIMENTO, S.C.; SILVA, J.F.; PEREIRA, E.C.G.; SILVA, N.H.; HONDA, N.K.; SANTOS-MAGALHÃES, N.S. Usnic acid-loaded nanocapsules: an evaluation of cytotoxicity. J. Drug Del. Sci. Technol., Paris, v.15, n.5, p.355-361, 2005.
19. SCIRPA, P.; SCAMBIA, G.; MASCIULLO, V.; BATTAGLIA, F.; FOTI, E.; LOPEZ, R.; VILLA, P.; MALECOE, M.; MANCUSO, S. Terapia adiuvante com um preparato a base di zinco solfato e acido úsnico delle lesioni genitali da Human Papilloma Vírus (HPV) dopo trattamento chirurgico distruttivo. Min. Ginecol., Torino, v.51, n.6, p.255-260, 1999.
20. TAKANI, M.; YAJIMA, T.; MASUDA, H.; YAMAUCHI, O. Spectroscopic and structural characterization of copper (II) and palladium (II) complexes of a lichen substance: usnic acid and its derivatives. Possible forms of environmental metals retained in lichens. J. Inorg. Biochem., New York, v.91, n.1, p.139-150, 2002.
21. UNITED States Pharmacopoeia. 26. ed. Rockville: United States Pharmacopoeial Convention, 2003. p.2439-2442.
22. VENKATARAMANA, D.; KRISHNA, D.R. High-performance liquid chromatographic determination of usnic acid in plasma. J. Chromatogr. Biomed. Appl., Amsterdam, v.575, n.1, p.167-170, 1992.